Skip to main content

Cho Dennis's Form 4 filing

Twist Bioscience Corp (TWST) · filed May 9, 2025

Accession no.
0001214659-25-007287
Filed
May 9, 2025
Trade date
May 7, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $163.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cho DennisCIK 0001883451Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 7, 2025Common StockSSaleDisposed−5,000$32.72F1−$163,600105,849Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average sales price per share. The shares sold at prices ranging from $32.71 to $32.755 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

Remarks

Senior Vice President, Chief Legal Officer & Corporate Secretary

Read the full filing on SEC EDGAR (opens in a new tab)